BeOne Medicines (ONC) Construction in Progress (2016 - 2026)
BeOne Medicines' (ONC) quarterly Construction in Progress came in at $152.7 million in Q2 2026, down 56.83% year-over-year from $353.7 million in Q2 2025, and up 11.08% quarter-over-quarter from $137.4 million in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Construction in Progress (2016 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Construction in Progress for 10 consecutive years, with $152.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Construction in Progress fell 56.83% year-over-year to $152.7 million in Q2 2026; TTM through Jun 2026 was $152.7 million, a 56.83% decrease from a year earlier, with the FY2025 full-year figure at $127.2 million, down 80.56% from the prior year.
- Construction in Progress was $152.7 million for Q2 2026 at BeOne Medicines, up from $137.4 million in the prior quarter.
- Over five years, Construction in Progress peaked at $863.4 million in Q2 2024 and troughed at $127.2 million in Q4 2025.
- A 5-year average of $430.5 million and a median of $376.9 million in 2023 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress soared 184.02% in 2023 and plunged 80.56% in 2025, its largest moves.
- Over 5 years, Construction in Progress stood at $293.6 million in 2022, then soared by 152.23% to $740.6 million in 2023, then declined by 11.69% to $654.0 million in 2024, then sank by 80.56% to $127.2 million in 2025, then gained by 20.06% to $152.7 million in 2026.
- The last three Construction in Progress figures came in at $152.7 million (Q2 2026), $137.4 million (Q1 2026), and $127.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 152.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 152.67 Mn |
| Mar 31, 2026 | 137.45 Mn |
| Dec 31, 2025 | 127.16 Mn |
| Sep 30, 2025 | 129.12 Mn |
| Jun 30, 2025 | 353.66 Mn |
| Mar 31, 2025 | 589.99 Mn |
| Dec 31, 2024 | 654.02 Mn |
| Sep 30, 2024 | 625.64 Mn |
| Jun 30, 2024 | 863.42 Mn |
| Mar 31, 2024 | 782.86 Mn |
| Dec 31, 2023 | 740.62 Mn |
| Sep 30, 2023 | 631.07 Mn |
| Jun 30, 2023 | 484.31 Mn |
| Mar 31, 2023 | 376.90 Mn |
| Dec 31, 2022 | 293.63 Mn |
| Sep 30, 2022 | 222.19 Mn |
| Mar 31, 2022 | 153.66 Mn |
| Dec 31, 2021 | 186.84 Mn |
| Sep 30, 2021 | 129.36 Mn |
| Jun 30, 2021 | 78.86 Mn |
API Access
BeOne Medicines Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();